Given that reduced muscle PGC1α–PPAR signaling in COPD is a consistent finding, we investigated muscle KAT expression and KYN blood samples in well-characterized samples from COPD patients versus healthy controls. This evidence concerns the gene PPARGC1A and chronic obstructive pulmonary disease.